Literature DB >> 16314951

Human leukocyte antigen distribution analysis in North Italian brain Glioma patients: an association with HLA-DRB1*14.

Franca R Guerini1, Cristina Agliardi, Milena Zanzottera, Serena Delbue, Elisabetta Pagani, Carmine Tinelli, Renzo Boldorini, Pier Giorgio Car, Claudia Veggiani, Pasquale Ferrante.   

Abstract

Human leukocyte antigens (HLA) are widely expressed cell surface molecules that present antigenic peptides to T-lymphocytes and modulate the immune response against inflammatory and malignant disease. Frequently, tumoral cells express antigens that are recognized by the immune system. Ineffective immune response could be the result of defects in antigen presentation in those subjects with peculiar HLA alleles, which, owing to mechanisms that are still unknown, are unable to carry out their function. Only a few studies on glioma and HLA association have been performed to date. The aim of our study was to characterize a group of Italian Caucasian patients with glioma, to investigate a possible association between HLA antigens and cerebral glioma tumorigenesis in Italian patients. HLA typing of class I and class II loci was done by molecular typing performed on blood DNA from 36 glioma patients from northern Italy. The data obtained were compared with HLA frequencies taken from the database of northern Italian organ donors.A positive association between HLA-DRB1*14 and the presence of symptomatic cerebral glioma was observed (p = 0.02, odds ratio = 2.48, 95% confidence interval: 1.09-5.45). This is the first Italian report on a case-control data study of HLA distribution conducted on a group of glioma patients and a first step in defining a possible involvement of HLA in susceptibility to brain glioma in the Italian population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314951     DOI: 10.1007/s11060-005-9032-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  34 in total

1.  The genetic epidemiology of glioma.

Authors:  R H Osborne; M P Houben; C C Tijssen; J W Coebergh; C M van Duijn
Journal:  Neurology       Date:  2001-11-27       Impact factor: 9.910

Review 2.  Treatment of malignant glioma in adults.

Authors:  P A Forsyth; J G Cairncross
Journal:  Curr Opin Neurol       Date:  1995-12       Impact factor: 5.710

3.  Tumor necrosis factor microsatellite polymorphisms in Italian glioblastoma patients.

Authors:  S Frigerio; E Ciusani; A Pozzi; A Silvani; A Salmaggi; A Boiardi
Journal:  Cancer Genet Cytogenet       Date:  1999-03

4.  HLA-DQBl alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients.

Authors:  Alamtaj Samsami Dehaghani; Ali Amirzargar; Shirin Farjadian; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

5.  Brain glioma and human leukocyte antigens (HLA)--is there an association.

Authors:  H K Machulla; F Steinborn; A Schaaf; V Heidecke; N G Rainov
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

6.  DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours.

Authors:  J Mollenhauer; S Wiemann; W Scheurlen; B Korn; Y Hayashi; K K Wilgenbus; A von Deimling; A Poustka
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

7.  HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.

Authors:  Clara Ballerini; Franca R Guerini; Giovanni Rombolà; Eleonora Rosati; Luca Massacesi; Pasquale Ferrante; Domenico Caputo; Lorenzo Figà Talamanca; Paola Naldi; Maria Liguori; Mehdi Alizadeh; Patricia Momigliano-Richiardi; Sandra D'Alfonso
Journal:  J Neuroimmunol       Date:  2004-05       Impact factor: 3.478

8.  HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma.

Authors:  V Luongo; G Pirozzi; C Caracò; S Errico; F de Angelis; E Celentano; F Paino; M G Chiofalo; M Luongo; N Mozzillo; M L Lombardi
Journal:  Tissue Antigens       Date:  2004-07

9.  Association of the HLA-DRB1 gene locus with gastric adenocarcinoma in Japan.

Authors:  M Ohtani; T Azuma; S Yamazaki; A Yamakawa; Y Ito; A Muramatsu; M Dojo; Y Yamazaki; M Kuriyama
Journal:  Dig Liver Dis       Date:  2003-07       Impact factor: 4.088

10.  Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection.

Authors:  Annapurna Vyakarnam; David Sidebottom; Shahed Murad; James A Underhill; Philippa J Easterbrook; Angus G Dalgleish; Mark Peakman
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

View more
  6 in total

1.  Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Authors:  Bryan A Bassig; Peter D Inskip; Laurie Burdette; William R Shapiro; Robert G Selker; Howard A Fine; Jay S Loeffler; Peter M Black; Robert Dubrow; Alina V Brenner
Journal:  J Neuroimmunol       Date:  2010-12-30       Impact factor: 3.478

2.  Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma.

Authors:  Chenan Zhang; Adam J de Smith; Ivan V Smirnov; John K Wiencke; Joseph L Wiemels; John S Witte; Kyle M Walsh
Journal:  J Neurooncol       Date:  2017-07-18       Impact factor: 4.130

3.  Glioma Indian scenario: Is there a human leucocyte antigen association?

Authors:  U Shankarkumar; B Sridharan
Journal:  J Nat Sci Biol Med       Date:  2011-07

4.  Analysis of gene expression profiles associated with glioma progression.

Authors:  Guozhang Hu; Bo Wei; Lina Wang; Le Wang; Daliang Kong; Ying Jin; Zhigang Sun
Journal:  Mol Med Rep       Date:  2015-04-01       Impact factor: 2.952

5.  HLA polymorphisms and risk of glioblastoma in Koreans.

Authors:  Sang-Soo Choi; Haeyoun Choi; In-Cheol Baek; Soon A Park; Jae-Sung Park; Tai-Gyu Kim; Sin-Soo Jeun; Stephen Ahn
Journal:  PLoS One       Date:  2021-12-09       Impact factor: 3.240

6.  Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs.

Authors:  Wei Song; Avima M Ruder; Liangyuan Hu; Yufeng Li; Rong Ni; Wenshuo Shao; Richard A Kaslow; MaryAnn Butler; Jianming Tang
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.